Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase

OBJECTIVE: Donepezil, an inhibitor of acetylcholinesterase (AChE) targeting the brain, is a common medication for Alzheimer's disease. Interestingly, a recent clinical study found that administration of this agent is associated with lower risk of hip fracture independently of falling, suggestin...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Heliyon
Main Authors: Sato, Tsuyoshi, Enoki, Yuichiro, Sakamoto, Yasushi, Yokota, Kazuhiro, Okubo, Masahiko, Matsumoto, Masahito, Hayashi, Naoki, Usui, Michihiko, Kokabu, Shoichiro, Mimura, Toshihide, Nakazato, Yoshihiko, Araki, Nobuo, Fukuda, Toru, Okazaki, Yasushi, Suda, Tatsuo, Takeda, Shu, Yoda, Tetsuya
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2015
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939821/
https://ncbi.nlm.nih.gov/pubmed/27441211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2015.e00013
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים